PTN6_HUMAN - dbPTM
PTN6_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PTN6_HUMAN
UniProt AC P29350
Protein Name Tyrosine-protein phosphatase non-receptor type 6
Gene Name PTPN6
Organism Homo sapiens (Human).
Sequence Length 595
Subcellular Localization Cytoplasm. Nucleus. In neurons, translocates into the nucleus after treatment with angiotensin II (By similarity). Shuttles between the cytoplasm and nucleus via its association with PDPK1..
Protein Description Modulates signaling by tyrosine phosphorylated cell surface receptors such as KIT and the EGF receptor/EGFR. The SH2 regions may interact with other cellular components to modulate its own phosphatase activity against interacting substrates. Together with MTUS1, induces UBE2V2 expression upon angiotensin II stimulation. Plays a key role in hematopoiesis..
Protein Sequence MVRWFHRDLSGLDAETLLKGRGVHGSFLARPSRKNQGDFSLSVRVGDQVTHIRIQNSGDFYDLYGGEKFATLTELVEYYTQQQGVLQDRDGTIIHLKYPLNCSDPTSERWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMCEGGRYTVGGLETFDSLTDLVEHFKKTGIEEASGAFVYLRQPYYATRVNAADIENRVLELNKKQESEDTAKAGFWEEFESLQKQEVKNLHQRLEGQRPENKGKNRYKNILPFDHSRVILQGRDSNIPGSDYINANYIKNQLLGPDENAKTYIASQGCLEATVNDFWQMAWQENSRVIVMTTREVEKGRNKCVPYWPEVGMQRAYGPYSVTNCGEHDTTEYKLRTLQVSPLDNGDLIREIWHYQYLSWPDHGVPSEPGGVLSFLDQINQRQESLPHAGPIIVHCSAGIGRTGTIIVIDMLMENISTKGLDCDIDIQKTIQMVRAQRSGMVQTEAQYKFIYVAIAQFIETTKKKLEVLQSQKGQESEYGNITYPPAMKNAHAKASRTSSKHKEDVYENLHTKNKREEKVKKQRSADKEKSKGSLKRK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
10PhosphorylationRWFHRDLSGLDAETL
CCCCCCCCCCCHHHH
41.4123401153
10 (in isoform 4)Phosphorylation-41.4127251275
12 (in isoform 3)Phosphorylation-5.1824719451
16PhosphorylationLSGLDAETLLKGRGV
CCCCCHHHHHCCCCC
38.8330108239
19AcetylationLDAETLLKGRGVHGS
CCHHHHHCCCCCCCE
50.0725953088
19UbiquitinationLDAETLLKGRGVHGS
CCHHHHHCCCCCCCE
50.0721906983
19 (in isoform 1)Ubiquitination-50.0721890473
21 (in isoform 3)Ubiquitination-42.2321890473
26PhosphorylationKGRGVHGSFLARPSR
CCCCCCCEEEECCCC
11.3823401153
26 (in isoform 4)Phosphorylation-11.3827251275
32PhosphorylationGSFLARPSRKNQGDF
CEEEECCCCCCCCCE
50.7830108239
34UbiquitinationFLARPSRKNQGDFSL
EEECCCCCCCCCEEE
58.94-
40PhosphorylationRKNQGDFSLSVRVGD
CCCCCCEEEEEEECC
25.1930108239
42PhosphorylationNQGDFSLSVRVGDQV
CCCCEEEEEEECCEE
13.4830108239
57PhosphorylationTHIRIQNSGDFYDLY
EEEEECCCCCCCCCC
24.3030108239
57 (in isoform 4)Phosphorylation-24.3027251275
61PhosphorylationIQNSGDFYDLYGGEK
ECCCCCCCCCCCCEE
15.1328796482
63 (in isoform 3)Phosphorylation-2.6627642862
64PhosphorylationSGDFYDLYGGEKFAT
CCCCCCCCCCEEEEE
21.8628796482
66 (in isoform 3)Phosphorylation-22.7425147952
97AcetylationDGTIIHLKYPLNCSD
CCCEEEEEEECCCCC
30.5725953088
97UbiquitinationDGTIIHLKYPLNCSD
CCCEEEEEEECCCCC
30.57-
98PhosphorylationGTIIHLKYPLNCSDP
CCEEEEEEECCCCCC
21.22-
111PhosphorylationDPTSERWYHGHMSGG
CCCCCCEEECCCCCC
12.25-
116PhosphorylationRWYHGHMSGGQAETL
CEEECCCCCCCHHHH
33.8124247654
138PhosphorylationWTFLVRESLSQPGDF
CEEEEEECCCCCCCE
23.8226657352
140PhosphorylationFLVRESLSQPGDFVL
EEEEECCCCCCCEEE
43.5426657352
140 (in isoform 4)Phosphorylation-43.5427251275
151O-linked_GlycosylationDFVLSVLSDQPKAGP
CEEEEEECCCCCCCC
31.8530379171
155UbiquitinationSVLSDQPKAGPGSPL
EEECCCCCCCCCCCC
61.41-
160PhosphorylationQPKAGPGSPLRVTHI
CCCCCCCCCCEEEEE
24.7225003641
168UbiquitinationPLRVTHIKVMCEGGR
CCEEEEEEEEECCCC
19.13-
176PhosphorylationVMCEGGRYTVGGLET
EEECCCCEEECCEEC
14.73-
177PhosphorylationMCEGGRYTVGGLETF
EECCCCEEECCEECC
16.0022115753
183PhosphorylationYTVGGLETFDSLTDL
EEECCEECCCHHHHH
37.4728450419
186PhosphorylationGGLETFDSLTDLVEH
CCEECCCHHHHHHHH
29.0428450419
188PhosphorylationLETFDSLTDLVEHFK
EECCCHHHHHHHHHH
31.1026657352
195UbiquitinationTDLVEHFKKTGIEEA
HHHHHHHHHHCCHHC
51.86-
196UbiquitinationDLVEHFKKTGIEEAS
HHHHHHHHHCCHHCC
51.55-
213PhosphorylationFVYLRQPYYATRVNA
EEEECCCCCEECCCH
9.44-
214PhosphorylationVYLRQPYYATRVNAA
EEECCCCCEECCCHH
14.2625839225
232UbiquitinationNRVLELNKKQESEDT
HHHHHHHCCCCCHHH
69.34-
233UbiquitinationRVLELNKKQESEDTA
HHHHHHCCCCCHHHH
59.22-
236PhosphorylationELNKKQESEDTAKAG
HHHCCCCCHHHHHHC
37.9730624053
238 (in isoform 2)Ubiquitination-62.3321890473
241UbiquitinationQESEDTAKAGFWEEF
CCCHHHHHHCHHHHH
51.65-
250O-linked_GlycosylationGFWEEFESLQKQEVK
CHHHHHHHHHHHHHH
41.2330379171
250PhosphorylationGFWEEFESLQKQEVK
CHHHHHHHHHHHHHH
41.2328450419
250 (in isoform 4)Phosphorylation-41.2327251275
253UbiquitinationEEFESLQKQEVKNLH
HHHHHHHHHHHHHHH
54.44-
257UbiquitinationSLQKQEVKNLHQRLE
HHHHHHHHHHHHHHC
53.70-
271UbiquitinationEGQRPENKGKNRYKN
CCCCCCCCCCCCCCC
70.38-
276PhosphorylationENKGKNRYKNILPFD
CCCCCCCCCCCCCCC
20.1328796482
277AcetylationNKGKNRYKNILPFDH
CCCCCCCCCCCCCCC
33.9819608861
277UbiquitinationNKGKNRYKNILPFDH
CCCCCCCCCCCCCCC
33.9821890473
277 (in isoform 1)Ubiquitination-33.9821890473
277UbiquitinationNKGKNRYKNILPFDH
CCCCCCCCCCCCCCC
33.9821890473
278 (in isoform 3)Phosphorylation-31.9027642862
279 (in isoform 3)Ubiquitination-4.5221890473
285PhosphorylationNILPFDHSRVILQGR
CCCCCCCCEEEEECC
30.0423312004
286MethylationILPFDHSRVILQGRD
CCCCCCCEEEEECCC
18.97115916953
294PhosphorylationVILQGRDSNIPGSDY
EEEECCCCCCCCCCC
34.9930108239
299PhosphorylationRDSNIPGSDYINANY
CCCCCCCCCCCCHHH
23.1428796482
301PhosphorylationSNIPGSDYINANYIK
CCCCCCCCCCHHHHC
9.5828796482
303 (in isoform 3)Phosphorylation-18.8627642862
306PhosphorylationSDYINANYIKNQLLG
CCCCCHHHHCCCCCC
15.7428796482
308UbiquitinationYINANYIKNQLLGPD
CCCHHHHCCCCCCCC
28.42-
308 (in isoform 3)Phosphorylation-28.4227642862
350O-linked_GlycosylationNSRVIVMTTREVEKG
CCEEEEEECCCHHCC
16.2930379171
352 (in isoform 2)Ubiquitination-36.4821890473
360UbiquitinationEVEKGRNKCVPYWPE
CHHCCCCCCCCCCCC
34.94-
364PhosphorylationGRNKCVPYWPEVGMQ
CCCCCCCCCCCCCCC
17.13-
374PhosphorylationEVGMQRAYGPYSVTN
CCCCCEECCCCCCCC
22.3328796482
377PhosphorylationMQRAYGPYSVTNCGE
CCEECCCCCCCCCCC
16.0628796482
378PhosphorylationQRAYGPYSVTNCGEH
CEECCCCCCCCCCCC
26.1228796482
379 (in isoform 3)Phosphorylation-3.5327642862
380PhosphorylationAYGPYSVTNCGEHDT
ECCCCCCCCCCCCCC
20.8928796482
387PhosphorylationTNCGEHDTTEYKLRT
CCCCCCCCCEEEECE
24.3528796482
388PhosphorylationNCGEHDTTEYKLRTL
CCCCCCCCEEEECEE
43.2928796482
390PhosphorylationGEHDTTEYKLRTLQV
CCCCCCEEEECEEEE
17.1528796482
391UbiquitinationEHDTTEYKLRTLQVS
CCCCCEEEECEEEEC
25.842190698
391 (in isoform 1)Ubiquitination-25.8421890473
393 (in isoform 3)Ubiquitination-29.2821890473
394PhosphorylationTTEYKLRTLQVSPLD
CCEEEECEEEECCCC
31.7928450419
398PhosphorylationKLRTLQVSPLDNGDL
EECEEEECCCCCCHH
13.5430108239
453S-nitrosocysteineAGPIIVHCSAGIGRT
CCCEEEECCCCCCCC
1.75-
453S-nitrosylationAGPIIVHCSAGIGRT
CCCEEEECCCCCCCC
1.7522178444
462PhosphorylationAGIGRTGTIIVIDML
CCCCCCCEEEEECCC
13.6128674151
474PhosphorylationDMLMENISTKGLDCD
CCCCCCCCCCCCCCC
35.3328674151
486UbiquitinationDCDIDIQKTIQMVRA
CCCCCHHHHHHHHHH
48.18-
496PhosphorylationQMVRAQRSGMVQTEA
HHHHHHHCCCCCCHH
21.11-
509PhosphorylationEAQYKFIYVAIAQFI
HHHHHHHHHHHHHHH
6.2219060867
521UbiquitinationQFIETTKKKLEVLQS
HHHHHHHHHHHHHHH
61.57-
522UbiquitinationFIETTKKKLEVLQSQ
HHHHHHHHHHHHHHC
51.97-
528PhosphorylationKKLEVLQSQKGQESE
HHHHHHHHCCCCCCC
29.6924247654
528 (in isoform 4)Phosphorylation-29.6927251275
530UbiquitinationLEVLQSQKGQESEYG
HHHHHHCCCCCCCCC
68.74-
530 (in isoform 3)Phosphorylation-68.7427642862
534PhosphorylationQSQKGQESEYGNITY
HHCCCCCCCCCCCCC
28.3821945579
534 (in isoform 4)Phosphorylation-28.3827251275
536PhosphorylationQKGQESEYGNITYPP
CCCCCCCCCCCCCCH
25.4221945579
536 (in isoform 3)Phosphorylation-25.4227642862
536 (in isoform 4)Phosphorylation-25.4227251275
538 (in isoform 3)Phosphorylation-23.6427642862
540PhosphorylationESEYGNITYPPAMKN
CCCCCCCCCCHHHHH
33.6921945579
541PhosphorylationSEYGNITYPPAMKNA
CCCCCCCCCHHHHHH
11.9221945579
543 (in isoform 3)Phosphorylation-34.2727642862
546UbiquitinationITYPPAMKNAHAKAS
CCCCHHHHHHHHHHH
53.76-
553PhosphorylationKNAHAKASRTSSKHK
HHHHHHHHCCCHHHH
35.0726074081
555PhosphorylationAHAKASRTSSKHKED
HHHHHHCCCHHHHHH
34.5523927012
556PhosphorylationHAKASRTSSKHKEDV
HHHHHCCCHHHHHHH
35.9623927012
557PhosphorylationAKASRTSSKHKEDVY
HHHHCCCHHHHHHHH
37.8623401153
557 (in isoform 3)Phosphorylation-37.8627642862
558 (in isoform 3)Phosphorylation-59.4724719451
559 (in isoform 3)Phosphorylation-40.4627642862
560UbiquitinationSRTSSKHKEDVYENL
HCCCHHHHHHHHHHH
60.38-
563 (in isoform 4)Phosphorylation-7.28-
564PhosphorylationSKHKEDVYENLHTKN
HHHHHHHHHHHHHCC
16.0621945579
566 (in isoform 3)Phosphorylation-21.3125147952
569PhosphorylationDVYENLHTKNKREEK
HHHHHHHHCCHHHHH
39.2121945579
570UbiquitinationVYENLHTKNKREEKV
HHHHHHHCCHHHHHH
50.12-
582PhosphorylationEKVKKQRSADKEKSK
HHHHHHHHHHHHHHC
38.02-
588PhosphorylationRSADKEKSKGSLKRK
HHHHHHHHCCCCCCC
43.25-
591PhosphorylationDKEKSKGSLKRK---
HHHHHCCCCCCC---
34.1615269224

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
536YPhosphorylationKinaseABL1P00519
PhosphoELM
536YPhosphorylationKinaseINSRP06213
PSP
536YPhosphorylationKinaseSRC64-PhosphoELM
536YPhosphorylationKinaseLCKP06239
PSP
536YPhosphorylationKinaseABL-FAMILY-GPS
536YPhosphorylationKinaseLYNP07948
PSP
536YPhosphorylationKinaseSRCP12931
PSP
538YPhosphorylationKinaseINSRP06213
GPS
538YPhosphorylationKinasePDGFRBP09619
GPS
553SPhosphorylationKinasePKG2Q13237
PSP
556SPhosphorylationKinasePKG2Q13237
PSP
557SPhosphorylationKinasePKG2Q13237
PSP
564YPhosphorylationKinaseSRC64-PhosphoELM
564YPhosphorylationKinaseABL-FAMILY-GPS
564YPhosphorylationKinaseSRCP12931
PSP
564YPhosphorylationKinaseLYNP07948
Uniprot
564YPhosphorylationKinaseLCKP06239
PSP
564YPhosphorylationKinaseABL1P00519
PhosphoELM
591SPhosphorylationKinasePRKCAP17252
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PTN6_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PTN6_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BCR_HUMANBCRphysical
9788431
CD72_HUMANCD72physical
12882840
CD22_HUMANCD22physical
9890995
FAK2_HUMANPTK2Bphysical
10747947
KSYK_HUMANSYKphysical
10747947
ROS1_HUMANROS1physical
11266449
LCP2_HUMANLCP2physical
9765283
LCK_HUMANLCKphysical
10617656
IL3RB_HUMANCSF2RBphysical
8246974
INSR_HUMANINSRphysical
7512963
LAIR1_HUMANLAIR1physical
11160222
P85A_HUMANPIK3R1physical
11160222
EPOR_HUMANEPORphysical
7889566
NOS1_HUMANNOS1physical
11511520
PHAG1_HUMANPAG1physical
10790433
CAV1_HUMANCAV1physical
12176037
HXA10_HUMANHOXA10physical
12145285
TYK2_HUMANTYK2physical
7629131
JAK1_HUMANJAK1physical
7629131
SSR2_HUMANSSTR2physical
9305905
EGFR_HUMANEGFRphysical
9733788
KIT_HUMANKITphysical
9528781
KIT_HUMANKITphysical
7684496
LAIR1_HUMANLAIR1physical
10660620
SHPS1_HUMANSIRPAphysical
10660620
PILRA_HUMANPILRAphysical
10660620
LAIR1_HUMANLAIR1physical
10764762
CTND1_HUMANCTNND1physical
10835420
KPCD_HUMANPRKCDphysical
11723252
KSYK_HUMANSYKphysical
10072516
BLNK_HUMANBLNKphysical
11356834
CD22_HUMANCD22physical
11356834
FAK2_HUMANPTK2Bphysical
10521452
SHPS1_HUMANSIRPAphysical
10660565
LCP2_HUMANLCP2physical
8760799
LCK_HUMANLCKphysical
11294838
STA5B_HUMANSTAT5Bphysical
9211920
THIO_HUMANTXNphysical
19561639
SMAG2_HUMANSAMD4Bphysical
22939629
SIG12_MOUSESiglecephysical
11171044
AIMP1_HUMANAIMP1physical
26344197
SYDC_HUMANDARSphysical
26344197
PTN2_HUMANPTPN2physical
26344197
TRIP6_HUMANTRIP6physical
26344197
SYVC_HUMANVARSphysical
26344197
OLIG1_HUMANOLIG1physical
25814554
FAK1_HUMANPTK2physical
25814554
LAT_HUMANLATphysical
27221712
PLCG1_HUMANPLCG1physical
27221712
PLCG2_HUMANPLCG2physical
27221712
ERBB4_HUMANERBB4physical
28065597
PTN12_HUMANPTPN12physical
28514442
PTN6_HUMANPTPN6physical
27432908
NUD16_HUMANNUDT16physical
27432908
NMNA1_HUMANNMNAT1physical
27432908
PTN12_HUMANPTPN12physical
27432908
BCR_HUMANBCRphysical
27432908
MACD1_HUMANMACROD1physical
27432908
RL7L_HUMANRPL7L1physical
27432908
AROS_HUMANRPS19BP1physical
27432908
RL37A_HUMANRPL37Aphysical
27432908
BRX1_HUMANBRIX1physical
27432908
SRP14_HUMANSRP14physical
27432908
RL36L_HUMANRPL36ALphysical
27432908
G45IP_HUMANGADD45GIP1physical
27432908
RL30_HUMANRPL30physical
27432908
EBP2_HUMANEBNA1BP2physical
27432908
DIM1_HUMANDIMT1physical
27432908
RPF2_HUMANRPF2physical
27432908
RRS1_HUMANRRS1physical
27432908
CH033_HUMANC8orf33physical
27432908
RL35A_HUMANRPL35Aphysical
27432908
SRSF5_HUMANSRSF5physical
27432908
CLH2_HUMANCLTCL1physical
27432908
PA2G4_HUMANPA2G4physical
27432908
RL18A_HUMANRPL18Aphysical
27432908
RL22L_HUMANRPL22L1physical
27432908
RPP30_HUMANRPP30physical
27432908
CDK1_HUMANCDK1physical
14699166

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PTN6_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-277, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; TYR-64 AND TYR-564,AND MASS SPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-536, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-509, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-536 AND TYR-564, ANDMASS SPECTROMETRY.
"Functional interaction between SHPTP1 and the Lyn tyrosine kinase inthe apoptotic response to DNA damage.";
Yoshida K., Kharbanda S., Kufe D.;
J. Biol. Chem. 274:34663-34668(1999).
Cited for: INTERACTION WITH LYN, AND PHOSPHORYLATION AT TYR-564.

TOP